Anavex Life Sciences Corp (AVXL)

[falconer66a]

PA-Lite?

Should we consider the Australian Therapeutic Goods Administration's new Special Access Scheme (SAS) approval for the confined prescription and use of blarcamesine as a reduced or fractional Provisional Approval (PA)?

Does Anavex now have a PA-Lite for blarcamesine in Australia?

More importantly, was this done by the TGA to slowly, incrementally ease into an eventual PA, allowing Anavex time to ramp up production and arrange for pharmacy availability? (Do Aussies follow the British terminology? Pharmacists are "Chemists?")

Will the sequence be: first, PA-Lite, then PA, then finally, full approval; all done in a slowed sequence that allows for full product production and sales? No complications of inaccessibility or unavailability.

Pretty smart, them TGA poohbahs.